These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 720048)

  • 1. The medicolegal significance of the package insert.
    Hirsh HL
    Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048
    [No Abstract]   [Full Text] [Related]  

  • 2. The medicolegal significance of the package insert.
    Hirsh HL
    J Fam Pract; 1977 Jun; 4(6):1141-3. PubMed ID: 874441
    [No Abstract]   [Full Text] [Related]  

  • 3. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 4. Power of the package insert.
    Chayet NL
    N Engl J Med; 1967 Dec; 277(23):1253-4. PubMed ID: 6072669
    [No Abstract]   [Full Text] [Related]  

  • 5. The package insert and the pharmacist's liability.
    Simonsmeier LM
    Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug reactions: the role of the package insert.
    Barnett FJ
    J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069
    [No Abstract]   [Full Text] [Related]  

  • 7. The package insert.
    JAMA; 1969 Feb; 207(7):1342. PubMed ID: 5818327
    [No Abstract]   [Full Text] [Related]  

  • 8. Notes on the package insert.
    JAMA; 1969 Feb; 207(7):1335-8. PubMed ID: 5818325
    [No Abstract]   [Full Text] [Related]  

  • 9. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
    Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 15. Sounding board. Hegemony in medicine revisited.
    Chayet NL
    N Engl J Med; 1976 Mar; 294(10):547-8. PubMed ID: 1250259
    [No Abstract]   [Full Text] [Related]  

  • 16. Medico-legal bulletin number 254: Drug package inserts.
    DeMarco FJ
    Med Leg Bull; 1974 Jun; 23(6):1-6. PubMed ID: 4846844
    [No Abstract]   [Full Text] [Related]  

  • 17. The medicolegal aspects of adverse drug reactions.
    Bernstein HN; Levine AM
    Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
    [No Abstract]   [Full Text] [Related]  

  • 18. Kudos to the Food and Drug Administration: reversal of the package insert warning for birth defects for oral contraceptives.
    Brent RL
    Teratology; 1989 Jan; 39(1):93-4. PubMed ID: 2718144
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic freedom.
    Trout ME
    J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient package inserts--instructions or intrusions?
    Harvey MW
    Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.